GlassScriptPhysician profile
Melissa O Smith
NPI 1467470849
$2,129.49
in general payments reported to CMS, 2019-2025
11 companies · $23.31 in 2025
The $23.31 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,782 · 2020: $30.40 · 2021: $18.62 · 2022: $101 · 2023: $85.49 · 2024: $88.30 · 2025: $23.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $197.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,776.80 | 2019 | |
| Ibsa Pharma INC. | $58.24 | 2023-2024 | Tirosint, Tirosint, Licart |
| Triad Life Sciences INC. | $58.02 | 2022 | |
| Horizon Therapeutics Plc | $56.07 | 2020-2023 | Krystexxa |
| Amgen INC. | $43.62 | 2024-2025 | Krystexxa |
| Osteomed LLC | $43.45 | 2022 | |
| Paratek Pharmaceuticals, INC. | $38.32 | 2023-2024 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.62 | 2021 | |
| Davol INC. | $16.37 | 2020 | |
| Progenacare Global, LLC | $14.88 | 2024 | |
| Musculoskeletal Transplant Foundation INC. | $5.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.